Skip Navigation

Cardiovascular Research 1998 39(1):136-147; doi:10.1016/S0008-6363(98)00093-5
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sys, S. U
Right arrow Articles by Brutsaert, D. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sys, S. U
Right arrow Articles by Brutsaert, D. L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Physiopharmacological evaluation of myocardial performance

how to study modulation by cardiac endothelium and related humoral factors?

Stanislas U Sys*, Gilles W De Keulenaer and Dirk L Brutsaert

Department of Physiology and Medicine, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium

* Corresponding address: Tel.: +32 3 218 02 77; Fax: +32 3 218 02 76; E-mail: stsys@ruca.ua.ac.be

Received 5 January 1998; accepted 11 March 1998

The first 150 words of the full text of this article appear below.


    1 Introduction — the reductionist approach: how far?
 
When conducting human or animal experiments in a search for an understanding of the regulation and dysfunction of the cardiovascular system, clinicians and scientists have been confronted with the complexity of this system. Although complexity could be studied at any magnification, it has, in general, followed a reductionist approach [1, 2]. In this way, by bypassing or eliminating as many interacting processes as possible, our view on cardiac performance has become ever narrower in scope. For example, excluding neurohumoral control and uncoupling the heart from the peripheral circulation reduced our experimental approach from in-situ animal experiments to isolated experimental conditions, as e.g. the Langendorff-perfused heart and various, more recent, modified versions of it, where the heart is no longer necessarily considered as an input–output pump with ventricular filling (end-diastolic pressure and volume) and cardiac output (systolic pressure and stroke volume) as major features. With the heart as a muscular . . . [Full Text of this Article]


    2 Endothelial modulation of myocardial performance — the need for cardiomyocyte cell membrane and cytoplasm
 

    3 Minimally required information — instantaneous force and triple control of it
 
3.1 Load and (in)activation
3.2 (Non)uniformity
3.3 Extracardiac modulators

    4 Specific properties of the isolated intact cardiomyocyte — the need for force measurement at physiologic lengths
 
4.1 Measurements of length
4.2 Measurement of force

    5 Specific properties of the isolated papillary muscle — the need for reappraisal
 
5.1 Nonuniformity in isolated papillary muscle
5.2 Importance of variations in isometric twitch duration
5.3 Isometric twitch duration and endothelial modulation of myocardial performance

    6 Conclusion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Handoko, R. R. Lamberts, E. M. Redout, F. S. de Man, C. Boer, W. S. Simonides, W. J. Paulus, N. Westerhof, C. P. Allaart, and A. Vonk-Noordegraaf
Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1752 - H1759.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Attal, V. Claes, S. Bobin, P. Chanson, P. Kamenicky, P. Zizzari, and Y. Lecarpentier
Growth hormone excess and sternohyoid muscle mechanics in rats
Eur. Respir. J., October 1, 2009; 34(4): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Lamberts, E. Caldenhoven, M. Lansink, G. Witte, R. J. Vaessen, J. A. St Cyr, and G. J. M. Stienen
Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1869 - H1876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Lamberts, M. J. J. M. F. Willemsen, N. G. Perez, P. Sipkema, and N. Westerhof
Acute and specific collagen type I degradation increases diastolic and developed tension in perfused rat papillary muscle
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H889 - H894.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Fransen, J. Hendrickx, D. L Brutsaert, and S. U Sys
Distribution and role of Na+/K+ ATPase in endocardial endothelium
Cardiovasc Res, December 1, 2001; 52(3): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. J. J. M. F. Willemsen, D. J. Duncker, R. Krams, M. A. Dijkman, R. R. Lamberts, P. Sipkema, and N. Westerhof
Decrease in coronary vascular volume in systole augments cardiac contraction
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H731 - H737.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M Shah, S. J Sollott, and E. G Lakatta
Physio-pharmacological evaluation of myocardial performance: an integrative approach
Cardiovasc Res, July 1, 1998; 39(1): 148 - 154.
[Full Text] [PDF]